Cargando…

SARS-CoV-2 Omicron infection, who will be developed into severe/critical diseases?

Detalles Bibliográficos
Autores principales:	Feng, Mudan, Lin, Qing, Xu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199428/ https://www.ncbi.nlm.nih.gov/pubmed/37210554 http://dx.doi.org/10.1186/s12967-023-04207-2

Ejemplares similares

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)

Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients
por: Lina, Liu, et al.
Publicado: (2022)

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection
por: Zheng, Jing, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland
por: Bell, Samira, et al.
Publicado: (2022)

Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness
por: Jiang, Li, et al.
Publicado: (2023)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

It is not the time to relax yet: masks are still needed for the Omicron variant of SARS-CoV-2
por: Lowe, Scott, et al.
Publicado: (2022)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron BA.5: Riding the seventh wave in Central Canada
por: Li, Anthony, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection
por: Davies, Jessica, et al.
Publicado: (2022)

Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea
por: Guo, Zihao, et al.
Publicado: (2022)

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals
por: Choi, Min Joo, et al.
Publicado: (2023)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
por: Mizoue, Tetsuya, et al.
Publicado: (2022)

Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children
por: Zhou, Jianguo, et al.
Publicado: (2023)

The risks of death and hospitalizations associated with SARS-CoV-2 Omicron declined after lifting testing and quarantining measures()
por: Deng, Yamin, et al.
Publicado: (2023)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
por: Castillo, P.R., et al.
Publicado: (2020)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8vg9rt2kd6vi7n6eevvcvc4st